参考文献

［1］HE YJ，XU H，FU YJ，et al.Intraperitoneal hypertension，a novel risk factor for sepsisassociated encephalopathy in sepsis mice.Sci Rep，2018，8（1）：8173.

［2］ZHANG LN，WANG XT，AI YH，et al.Epidemiological features and risk factors of sepsis-associated encephalopathy in intensive care unit patients：2008-2011.Chin Med J（Engl），2012，125（5）：828-831.

［3］SILVESTRE F，DANIELSKI LG，MICHELS M，et al.Effects of organoselenium compounds on early and late brain biochemical alterations in sepsis-survivor rats.Neurotox Res，2014，26（4）：382-391.

［4］刘大为.实用重症医学.2版.北京：人民卫生出版社，2018.

［5］MACGOWAN AP，MACNAUGHTON E.Antimicrobial therapy：principles of use.Medicine，2013，41（11）：635-641.

［6］PASHAZADEH A，FRIEBE M.Radioguided surgery：physical principles and an update on technological developments.Biomedizinische Technik，2019，65（1）：1-10.

［7］DENG J，LIANG H.Clinical significance and principles of the specification procedures for lymph node examination after curative surgery for gastric cancer.Zhonghua Wei Chang Waike Zazhi，2018，21（10）：1183-1190.

［8］KEPLER CK，DIVI SN，BRONSON WH，et al.General principles in the consensus of SSI management after spine surgery.Clin Spine Surg，2019，33（5）：1-8.

［9］HUANG J，CAO C，NELSON G，et al.A review of enhanced recovery after surgery principles used for scheduled caesarean delivery.J Obstet Gynaecol Can，2019，41（12）：1775-1788.

［10］ACHEAMPONG A，VINCENT JL.A positive fluid balance is an independent prognostic factor in patients with sepsis.Crit Care，2015，19（1）：251.

［11］BROTFAIN E，KOYFMAN L，TOLEDANO R，et al.Positive fluid balance as a major predictor of clinical outcome of patients with sepsis/septic shock after ICU discharge.Am J Emerg Med，2016，34（11）：2122-2126.

［12］MITCHELL KH，CARLBOM D，CALDWELL E，et al.Volume overload：prevalence，risk factors，and functional out come in survivors of septic shock.Ann Am Thorac Soc，2015，12（12）：1837-1844.

［13］DE OLIVEIRA FS，FREITAS FG，FERREIRA EM，et al.Positive fluid balance as a prognostic factor for mortality and acute kidney injury in severe sepsis and septic shock.J Crit Care，2015，30（1）：97-101.

［14］《抗菌药物临床应用直到原则》修订组.抗菌药物临床应用指导原则（2015年版）.国卫办医发（2015）43号附件.

［15］HASHIMOTO SATORU，SANUI MASAMITSU，EGI MORITOKI，et al.The clinical practice guideline for the management of ards in JAPAN.J Intensive Care，2017，5：50.

［16］GUERIN C，REIGNIER J，RICHARD JC，et al.Prone positioning in severe acute respiratory distress syndrome.N Engl J Med，2013，368（23）：2159-2168.

［17］BORGES JB，OKAMOTO VN，MATOS GF，et al.Reversibility of lung collapse and hypoxemia in early acute respiratory distress syndrome.Am J Respir Crit Care Med，2006，174（3）：268-278.

［18］SUZUMURA EA，FIGUEIRO M，NORMILIO-SILVA K，et al.Effects of alveolar recruitment maneuvers on clinical outcomes in patients with acute respiratory distress syndrome：a systematic review and meta-analysis.Intensive Care Med，2014，40（9）：1227-1240.

［19］中华医学会老年医学分会，《中华老年医学杂志》编辑委员会.肠道微生态制剂老年人临床应用中国专家共识（2019）.中华老年医学杂志，2019，38（4）：355-361.

［20］Writing Group for the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial（ART）Investigators，CAVALCANTI AB，SUZUMURA EA，et al.Effect of lung recruitment and titrated positive end-expiratory pressure（PEEP）vs low PEEP on mortality in patients with acute respiratory distress syndrome：a randomized clinical trial.JAMA，2017，318（14）：1335-1345.

［21］PLADYS P，VANDENBROUCKE L，HERNANDEZ A，et al.The benefits of measuring heart rate variability in sepsis.Réanimation，2015，24（2）：315-321.

［22］LENZ K.Internistische Intensivmedizin in sterreich.Intensivmedizin Und Notfallmedizin，2008，45（4）：167-170.

［23］LANGLEY RJ，WONG HR.Early diagnosis of sepsis：is an integrated omics approach the way forward？ Mol Diagn Ther，2017，21（5）：525-537.

［24］MATTHAY MA，ZEMANS RL，ZIMMERMAN GA，et al.Acute respiratory distress syndrome.Nat Rev Dis Primers，2019，5（1）：18.

［25］COMBES A，BRODIE D，BARTLETT R，et al.Position paper for the organization of extracorporeal membrane oxygenation programs for acute respiratory failure in adult patients.Am J Respir Crit Care Med，2014，190（5）：488-496.

［26］JOHNSON S，LOUIE TJ，GERDING DN，et al.Vancomycin，metronidazole，or tolevamer for Clostridium difficile infection：results from two multinational，randomized，controlled trials.Clin Infect Dis，2014，59（3）：345-354.

［27］BARKER AK，DUSTER M，VALENTINE S，et al.A randomized controlled trial of probiotics for Clostridium difficile infection in adults（PICO）.J Antimicrob Chemother，2017，72（11）：3177-3180.

［28］郭玉红，刘清泉.脓毒症心肌功能障碍的研究进展.中华急诊医学杂志，2017，26（3）：361-366.

［29］TRAN TT，MATHIEU C，TORRES M，et al.Effect of landiolol on sex-related transcriptomic changes in the myocardium during sepsis.Intens Care Med Exper，2019，7（1）：50.

［30］ANDREWS D，CHETTY Y，COOPER BS，et al.Multiplex PCR point of care testing versus routine，laboratory-based testing in the treatment of adults with respiratory tract infections：a quasi-randomised study assessing impact on length of stay and antimicrobial use.BMC Infect Dis，2017，17（1）：671.

［31］PATIL SM，ARORA N，NILSSON P，et al.Native valve infective endocarditis with osteomyelitis and brain abscess caused by Granulicatella adiacens with literature review.Case Rep Infect Dis，2019，2019：4962392.

［32］孙田杰.外科护理学.2版.上海：上海科学技术出版社，2016.

［33］ZYWOT A，LAU CSM，STEPHEN FLETCHER H，et al.Bundles prevent surgical site infections after colorectal surgery：meta-analysis and systematic review.J Gastrointest Surg，2017，21（11）：1915-1930.

［34］中华医学会血液学分会血栓与止血学组.弥散性血管内凝血诊断中国专家共识（2017年版）.中华血液学杂志，2017，38（5）：361-363.

［35］The Bluebelle Study Group，REEVES BC，ANDRONIS L，et al.A mixed-methods feasibility and external pilot study to inform a large pragmatic randomised controlled trial of the effects of surgical wound dressing strategies on surgical site infections（Bluebelle Phase B）：study protocol for a randomised controlled trial.Trials，2017，18（1）：401.

［36］中华医学会血液学分会，中国医师协会血液科医师分会.中国中性粒细胞缺乏伴发热患者抗菌药物临床应用指南（2016年版）.中华血液学杂志，2017，37（5）：353-359.

［37］BUETTNER S，ETHUN CG，POULTSIDES G，et al.Surgical site infection is associated with tumor recurrence in patients with extrahepatic biliary malignancies.J Gastrointest Surg，2017，21（11）：1813-1820.

［38］EROGLU A，D KARASOY，KURT H，et al.National Practice in Antibiotic Prophylaxis in Breast Cancer Surgery［J］.Journal of Clinical Medicine Research，2014，6（1）：30-35.

［39］HEDRICK TL，SAWYER RG.Surgical infections.Surg Clin N Am，2014，94（6）：xvii-xviii.

［40］EDMISTON CE，SPENCER M.Going forward：preventing surgical site infections in 2015.AORN J，2014，100（6）：616-619.

［41］ELSOLH B，ZHANG L，PATEL SV.The effect of antibiotic-coated sutures on the incidence of surgical site infections in abdominal closures：a meta-analysis.J Gastrointest Surg，2017，21（5）：896-903.

［42］赵小义.外科护理.2版.西安：第四军医大学出版社，2014.

［43］MALBRAIN ML，MARIK PE，WITTERS I，et al.Fluid overload，deresuscitation，and outcomes in critically ill or injured patients：a systematic review with suggestions for clinical practice.Anaesthesiol Intensive Ther，2014，46（5）：361-380.

［44］ANNANE D，BELLISSANT E，BOLLAERT PE，et al.Corticosteroids in the treatment of severe sepsis and septic shock in adults：a systematic review.JAMA，2009，301（22）：2362-2375.

［45］CIMOLAI MC，ALVAREZ S，BODE C，et al.Mitochondrial mechanisms in septic cardiomyopathy.Int J Mol Sci，2015，16（8）：17763-17778.

［46］张哲英，张蓓，秦静，等.多器官功能障碍综合征患者血清对内皮细胞氧化损伤的影响及还原型谷胱甘肽的保护作用.中国急救医学，2015，35（1）38-43.

［47］SINGER P，BLASER AR，BERGER MM，et al.ESPEN guideline on clinical nutrition in the intensive care unit.Clin Nutr，2019，38（1）：48-79.

［48］PLAUTH M，BERNAL W，DASARATHY S，et al.ESPEN guideline on clinical nutrition in liver disease.Clin Nutr，2019，38（2）：485-521.

［49］GAUDRY S，HAJAGE D，SCHORTGEN F，et al.Initiation strategies for renal-replacement therapy in the intensive care unit.N Engl J Med，2016，375（2）：122-133.

［50］BARBAR SD，CLERE-JEHL R，BOURREDJEM A，et al.Timing of renal-replacement therapy in patients with acute kidney injury and sepsis.N Engl J Med，2018，379（15）：1431-1442.

［51］LAI TS，SHIAO CC，WANG JJ，et al.Earlier versus later initiation of renal replacement therapy among critically ill patients with acute kidney injury：a systematic review and meta-analysis of randomized controlled trials.Ann Intensive Care，2017，7（1）：38.

［52］MEERSCH M，KULLMAR M，SCHMIDT C，et al.Long-term clinical outcomes after early initiation of RRT in critically ill patients with AKI.J Am Soc Nephrol，2018，29（3）：1011-1019.

［53］AVNI T，LADOR A，LEV S，et al.Vasopressors for the treatment of septic shock：systematic review and meta-analysis.PLoS One，2015，10（8）：e0129305.

［54］GORDON AC，RUSSELL JA，WALLEY KR，et al.The effects of vasopressin on acute kidney injury in septic shock.Intensive Care Med，2010，36（1）：83-91.

［55］SONG F，ZHONG LJ，HAN L，et al.Intensive insulin therapy for septic patients：a metaanalysis of randomized controlled trials.Biomed Res Int，2014，2014：698265. kooU/HKXueCr4vpfDFBv9SyP0kWbk1mES2lvU2/9KQTXMLqpUnKQsGL1TrNVkRpC